Transplantation in the over 60’s 6 year experience E.R Faulconer N.G. Inston D. van Dellen H. Krishnan I. Griveas.

Slides:



Advertisements
Similar presentations
UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
Advertisements

The future of haemodialysis in the UK RCP advanced medicine 2013 Cormac Breen Consultant Nephrologist Guy's and St Thomas' Hospitals London.
This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used for non-commercial study and educational.
UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
UK Renal Registry 15th Annual Report Figure 8.1. Age and gender of PD patients submitted to audit.
Access to transplant in the UK The ATTOM study Dr Rommel Ravanan On behalf of ATTOM investigators.
UK Renal Registry 16th Annual Report Figure 5.1. Flow chart showing number of patients included in the various analyses.
USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.
Sample Size Determination
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
CKD Conservative care and preparation for dialysis UK Renal Registry 2013 Annual Audit Meeting Dr Anirudh Rao Registrar, UK Renal Registry.
Living Donor Kidney Transplant. What does the evidence say about outcome ? Professor Peter J Conlon.
Allocation of elderly deceased donor kidneys Lisa Bradbury, Niaz Ahmad, Paul Gibbs, Richard Baker, Adam McLean, Chris Callaghan Renal Transplant Services.
Kidney Transplant: A Realistic Chance for Elderly Patients Reference: Munnapradist S, Danovitch GM. Kidney transplants for the elderly: Hope or hype? Clin.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
Vascular access The KidneyCare Audit. The challenge of vascular access – Renal National Service Framework Standard 3 “All children, young people and adults.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
ETHNIC DISPARITIES IN KIDNEY TRANSPLANTATION: REPLACEMENT OF RENAL FUNCTION IN ROMA („GYPSIE“) MINORITY IN CROATIA Milica Kljak University Hospital Centre.
UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate
Experience with Calcineurin Inhibitor-Free Immunosuppression in Kidney Transplantation with Marginal Donors Oppenheimer F, Saval N, Gutierrez A, Cam pistol.
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
Information, Quality and Values Donal O’Donoghue National Clinical Director for Kidney Care Working for better kidney care UKRR and NHS Kidney Care Information.
Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
Registry Report Highlights and Insights in 2007/8 User Group 2008.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
Survival after graft failure Dr Lynsey Webb Registrar UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
Access to renal transplantation Chris Dudley UKRR/UKT Joint analysis.
UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients
Quebec experience from 2003 to 2009 M Carrier MD, JF Lize MD and Quebec transplant programs Impact of Expanded Criteria Donors on outcomes of recipients.
What happens to patients returning to dialysis after transplant failure? Data from the UK Renal Registry Dr Lynsey Webb 1, Dr Anna Casula 1, Dr Charlie.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Similar Outcomes With Hemodialysis and Peritoneal.
Chronic Haemodialysis therapy in octogenarians with ESRF: demographics and outcomes from a single centre in England Dr Punit Yadav Dr Jyoti Baharani.
Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.
Access to transplant in the UK The ATTOM study Dr Rommel Ravanan On behalf of ATTOM investigators.
Renal Transplant Audit (including liver+kidney) 2010 David Milford Department of Nephrology Birmingham Children’s Hospital.
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 15th Annual Report
Fig 7.1 Median URR achieved in each renal unit
UK Renal Registry 16th Annual Report
UK Renal Registry 18th Annual Report
UK Renal Registry 9th Annual Report 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 19th Annual Report
CHAPTER 5 Paediatric Renal Replacement Therapy
UK Renal Registry 13th Annual Report
UK Renal Registry 11th Annual Report
UK Renal Registry 11th Annual Report 2008
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
UK Renal Registry 13th Annual Report
Fig 6.1 Frequency of ischaemic heart disease in incident patients
UK Renal Registry 11th Annual Report
UK Renal Registry 14th Annual Report
2013 Annual Report - 36th Edition
UK Renal Registry 12th Annual Report
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 12th Annual Report
UK Renal Registry 13th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 11th Annual Report
Dialysis outcomes in Australia & New Zealand
Survival of End Stage Renal Failure Patients with Cancer
Presentation transcript:

Transplantation in the over 60’s 6 year experience E.R Faulconer N.G. Inston D. van Dellen H. Krishnan I. Griveas

Is Age An Issue? Age at starting Dialysis? Age at going on waiting list? Age at actual transplant operation? Does this matter? What do we know and does our data support this?

What is Survival on Dialysis Prognosis –Life expectancy –HD: 8 years Ansell D, Roderick P, et.al. UK Renal Registry 11 th Annual Report. Nephron Clin Pract 2009, 111 (suppl 1): c

Renal registry 2009 vs 2001 The ESRF RRT population is getting older

Why should listing take longer if you are older? More tests Improved health if they stay alive and you get to know them (they probably will be ok)

Incident Patient Survival on Dialysis Without transplantation censoring ( ) Censored for transplantation ( ) Ansell D, Roderick P, et.al. UK Renal Registry 11 th Annual Report. Nephron Clin Pract 2009, 111 (suppl 1): c

Risk/Benefit of Transplantation This applies to US patients – but does it apply to the 73 year old (n=1) in listing clinic? No….

So if you are over 60 it takes longer to get the benefit

So if you are over 60 it takes longer to get the benefit unless you have diabetes (significant comorbidity) Should we transplant elderly Diabetics more readily?

in addition it takes 369 days to get to a survival equal to reference (that is dialysis on W/L ie pre-tx state

For a projected years of life of 10 vs 6

So the graph actually shifts to the left and upwards!

Outline Defined 2 Groups –> 60 –<60 Audited cohort from Outcome measures at 1 year –Survival –Graft loss –CMV –Wound infection –Chest infection Analysed with reference to immunosuppressive protocols

Audited cohort from Overall transplants n= 658 –Under 60n= 551 –Over 60n=107 –Median ages and ranges

Birmingham – transplants by year Number Proportion

Demographics – Confounding Factors? Age <60Age >60p Total Immunosuppression TMP NAP TAP NMP 368 (67%) 66 (12%) 93 (17%) 25 (4%) 81 (76%) 15 (14%) 8 (7%) 3 (3%) Type of Transplant Live Cadaveric NHBD 261 (47%) 226 (41%) 64 (12%) 39 (37%) 57 (53%) 11 (10%) I/S included Basiliximab at D0 and D4 Fisher’s Exact Test

Immunosuppressive Regimen Used

1 year Patient Survival GroupSurvival Total97.7% < 60 y.o.98.5% > 60 y.o.93.4%

1 year Graft survival GroupSurvival Total93.4% < 60 y.o.94.1% > 60 y.o.89.7%

Cause of Death

Immunosuppression Regimens - Complications I/S regimeAgeN=CMVGraft lossWoundChestDeathAR NAPS < > TMPS < > NMPS < > TAPS < >

How do we decide if a patient is listed or not? Standards and guidelines –Against age discrimination –Based on tests and investigations Evidence base –Generally poor with regard to elderly –Most (pharma) RCTs exclude >55yrs –Registry data Gut feeling and experience –Is this really true?...

What are we listing for? Quality of life NOT Quantity of life Is there any proof of this? –This cannot be unbiased because it relies on: Survivors Not controllable – –HD vs PD vs “working” transplant vs “problem” transplant vs….

So how can we optimise and improve outcomes in elderly transplants? Listing –Conservative vs optimistic Assessment –Echo vs Stress vs CPEX Organ allocation –SCD vs ECD Immunosuppression –standard vs Minimise I/S?

Discussion…

Death

Graft Loss

Chest Complications

CMV Infection/Disease

Wound Complications

Chest Complications